Skin and metabolic syndrome: A review of the possible associations
January 2021
in “Journal of Research in Medical Sciences”
TLDR
Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.
The document reviews the associations between various medications and metabolic syndrome. It states that glucocorticoid use is not linked with metabolic syndrome in rheumatoid arthritis patients. Early life antibiotic exposure can impact pancreatic islet development and metabolic regulation. The antibiotic minocycline can lessen severe hyperglycemia in lipodystrophy patients, and low dose doxycycline can enhance glycemic control, lipid profiles, and islet morphology and function. The document also explores the effects of other medications like isotretinoin, methotrexate, tacrolimus, cyclosporine, anti-TNF-α therapy, hydroxychloroquine, H1 antihistamine, and spironolactone on metabolic syndrome. For example, isotretinoin does not cause insulin resistance in acne patients, methotrexate therapy is associated with a reduced prevalence of metabolic syndrome in rheumatoid arthritis patients over 60, and spironolactone improves glucose and lipid metabolism by reducing hepatic steatosis and inflammation.
View this study on journals.lww.com →
Cited in this study
research Metabolic syndrome and the skin: a more than superficial association. Reviewing the association between skin diseases and metabolic syndrome and a clinical decision algorithm for high risk patients
research Acanthosis nigricans and the metabolic syndrome

research Androgenetic alopecia, metabolic syndrome, and insulin resistance: Is there any association? A case-control study
Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

research Androgenetic alopecia and cardiovascular risk factors in men and women: A comparative study
Hair loss linked to higher heart disease risk in both men and women.
research Increased Insulin Sensitivity by Metformin Enhances Intense-Pulsed-Light-Assisted Hair Removal in Patients with Polycystic Ovary Syndrome

research Early androgenetic alopecia as a marker of insulin resistance
Early hair loss may indicate risk of insulin resistance.